DK114978B - Fremgangsmåde til fremstilling af (3-amino-pyrazinoyl)-guanidin-forbindelser eller salte heraf. - Google Patents

Fremgangsmåde til fremstilling af (3-amino-pyrazinoyl)-guanidin-forbindelser eller salte heraf.

Info

Publication number
DK114978B
DK114978B DK512263AA DK512263A DK114978B DK 114978 B DK114978 B DK 114978B DK 512263A A DK512263A A DK 512263AA DK 512263 A DK512263 A DK 512263A DK 114978 B DK114978 B DK 114978B
Authority
DK
Denmark
Prior art keywords
pyrazinoyl
salts
amino
preparation
guanidine compounds
Prior art date
Application number
DK512263AA
Other languages
Danish (da)
English (en)
Inventor
E Cragoe
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK114978B publication Critical patent/DK114978B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK512263AA 1962-10-30 1963-10-30 Fremgangsmåde til fremstilling af (3-amino-pyrazinoyl)-guanidin-forbindelser eller salte heraf. DK114978B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23423062A 1962-10-30 1962-10-30
US313315A US3313813A (en) 1962-10-30 1963-10-07 (3-amino-5, 6-disubstituted-pyrazinoyl) guanidines

Publications (1)

Publication Number Publication Date
DK114978B true DK114978B (da) 1969-08-25

Family

ID=26927694

Family Applications (4)

Application Number Title Priority Date Filing Date
DK512263AA DK114978B (da) 1962-10-30 1963-10-30 Fremgangsmåde til fremstilling af (3-amino-pyrazinoyl)-guanidin-forbindelser eller salte heraf.
DK453364AA DK116943B (da) 1962-10-30 1964-09-14 Fremgangsmåde til fremstilling af (3-amino-5,6-disubstituerede-pyrazinoyl)-guanidinforbindelser eller syreadditionssalte deraf.
DK619865AA DK114557B (da) 1962-10-30 1965-12-02 Fremgangsmåde til fremstilling af pteridin-forbindelser.
DK619765AA DK115403B (da) 1962-10-30 1965-12-02 Fremgangsmåde til fremstilling af (3-amino-pyrazinoyl)-guanidiner.

Family Applications After (3)

Application Number Title Priority Date Filing Date
DK453364AA DK116943B (da) 1962-10-30 1964-09-14 Fremgangsmåde til fremstilling af (3-amino-5,6-disubstituerede-pyrazinoyl)-guanidinforbindelser eller syreadditionssalte deraf.
DK619865AA DK114557B (da) 1962-10-30 1965-12-02 Fremgangsmåde til fremstilling af pteridin-forbindelser.
DK619765AA DK115403B (da) 1962-10-30 1965-12-02 Fremgangsmåde til fremstilling af (3-amino-pyrazinoyl)-guanidiner.

Country Status (13)

Country Link
US (1) US3313813A (fi)
BE (1) BE639386A (fi)
BR (1) BR6354164D0 (fi)
CH (1) CH465617A (fi)
CY (1) CY440A (fi)
DE (2) DE1795438C2 (fi)
DK (4) DK114978B (fi)
FI (1) FI47102C (fi)
FR (1) FR1563612A (fi)
GB (1) GB1066855A (fi)
MY (1) MY6900026A (fi)
NL (2) NL142413B (fi)
SE (1) SE321230B (fi)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6409714A (fi) * 1962-10-30 1965-10-01
US3472848A (en) * 1966-11-17 1969-10-14 Merck & Co Inc 3-hydroxy and 3-mercapto-pyrazinoyl-guanidines,corresponding ethers and thioethers and processes for their preparation
US3948895A (en) * 1971-09-28 1976-04-06 E. I. Du Pont De Nemours And Company Synthesis of 3,5-diaminopyrazinoic acid from 3,5-diamino-2,6-dicyanopyrazine and intermediates
US4085211A (en) * 1975-12-15 1978-04-18 Merck & Co., Inc. Pyrazinecarboxamides and processes for preparing same
US4087526A (en) * 1976-07-23 1978-05-02 Merck & Co., Inc. (3-Amino-5-substituted-6-fluoropyrazinoyl or pyrazamido)-guanidines and their derivatives bearing substituents on the guanidino nitrogens
US4208413A (en) * 1977-03-04 1980-06-17 Merck & Co., Inc. N-Pyrazinecarbonyl-N'-alkoxycarbonyl and N',N"-bis(alkoxycarbonyl)guanidines and processes for preparing same
US4108859A (en) * 1977-06-06 1978-08-22 The Dow Chemical Company Microbicidal (pyridinylamino) alkyl guanidines
US4140776A (en) * 1977-09-16 1979-02-20 Merck & Co., Inc. N-pyrazinecarbonyl-N'-acylguanidines
US4190655A (en) * 1978-08-28 1980-02-26 Merck & Co., Inc. Amiloride citrate
EP0009054A1 (en) * 1978-09-19 1980-04-02 Merck & Co. Inc. N-Pyrazinecarbonyl-N'-substituted-sulfamoyl-guanidine and processes for preparing same
US4224447A (en) * 1979-03-27 1980-09-23 Merck & Co., Inc. Novel pyrazinecarboxamides and processes for preparing same
US4246406A (en) * 1979-03-27 1981-01-20 Merck & Co., Inc. Heterocyclic substituted pyrazinoylguanidines
US4362724A (en) * 1980-05-19 1982-12-07 Merck & Co., Inc. Method of treating edema and hypertension and pharmaceutical composition therefor in which the active ingredient comprises a novel substituted pyrazinyl-1,2,4-oxadiazole and a kaliuretic diuretic
US4309540A (en) * 1980-05-19 1982-01-05 Merck & Co., Inc. Substituted pyrazinyl-1,2,4-oxadiazoles
US4454132A (en) * 1981-03-16 1984-06-12 Merck & Co., Inc. Pharmaceutical compositions of novel substituted pyrazinyl-1,2,4-oxadiazoles useful in the treatment of edema and hypertension
US4510322A (en) * 1981-07-13 1985-04-09 Merck & Co., Inc. Indacrinone having enhanced uricosuric
US4952582A (en) * 1982-01-04 1990-08-28 Beyer Jr Karl H Pyrazinoylguanidine and derivatives thereof having few polar substituents and being useful as hyperuretic agents
US4663322A (en) * 1982-01-04 1987-05-05 Beyer Jr Karl H Antihypertensive hyperuretic and saluretic agent combinations
DE3312516A1 (de) * 1983-04-07 1984-10-11 Brigitte Dr. 7400 Tübingen Pfeiffer Kernsubstituierte phenylalkylenguanidinderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
US4604394A (en) * 1984-10-01 1986-08-05 Merck & Co., Inc. Antiarrhythmic compositions and method
DE3925847A1 (de) * 1989-08-04 1991-02-07 Huels Chemische Werke Ag Verfahren zur herstellung von 3-aminopyrazin-2-carbonsaeuremethylester
US5304125A (en) * 1990-10-05 1994-04-19 The University Of North Carolina Apparatus for administering solid particulate aerosols to the lungs
EP0551445A4 (en) * 1990-10-05 1994-05-11 Univ North Carolina Method of administering amiloride
TW213903B (fi) * 1991-08-16 1993-10-01 Boehringer Ingelheim Kg
US6169107B1 (en) 1993-04-28 2001-01-02 Sumitomo Pharmaceutical Co., Ltd. Indoloylguanidine derivatives
DE4337609A1 (de) * 1993-11-04 1995-05-11 Boehringer Ingelheim Kg Neue Pyrazincarboxamidderivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
US5656256A (en) * 1994-12-14 1997-08-12 The University Of North Carolina At Chapel Hill Methods of treating lung disease by an aerosol containing benzamil or phenamil
TW372967B (en) * 1994-12-27 1999-11-01 Kanebo Ltd 1,4 benzoxazine derivative, pharmaceutical composition containing the same and use thereof
US5635160A (en) 1995-06-07 1997-06-03 The University Of North Carolina At Chapel Hill Dinucleotides useful for the treatment of cystic fibrosis and for hydrating mucus secretions
US5628984A (en) * 1995-07-31 1997-05-13 University Of North Carolina At Chapel Hill Method of detecting lung disease
US5801177A (en) * 1995-12-14 1998-09-01 Beyer, Jr.; Karl H. Method for controlling and/or lowering serum glucose and fatty acid concentrations and hypertensive blood pressure in non-insulin-dependent diabetic patients
US5877217A (en) * 1995-12-26 1999-03-02 Alteon Inc. N-acylaminoalkyl-hydrazinecarboximidamides
WO1999009998A1 (en) * 1997-08-29 1999-03-04 The University Of North Carolina At Chapel Hill Use of uridine 5'-diphosphate and analogs thereof for the treatment of lung diseases
CA2346656A1 (en) 1998-10-20 2000-04-27 The University Of North Carolina At Chapel Hill Methods of hydrating mucosal surfaces
WO2000044382A1 (en) * 1999-01-29 2000-08-03 BEYER, Camille, F. Composition and method for treating diabetes
PT1196396E (pt) 1999-07-19 2008-05-14 Univ North Carolina Compostos farmacologicamente activos com dois princípios activos covalentemente ligados (bloqueador dos canais do sódio/agonista do receptor p2y2) para o tratamento de superfícies mucosas
SK5992003A3 (en) 2000-11-21 2003-11-04 Sankyo Co Medicinal composition comprising an angiotensin II receptor antagonist and one or more diuretics and use thereof
US6858615B2 (en) * 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US6858614B2 (en) * 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenolic guanidine sodium channel blockers
US7704995B2 (en) * 2002-05-03 2010-04-27 Exelixis, Inc. Protein kinase modulators and methods of use
CA2484209C (en) * 2002-05-03 2013-06-11 Exelixis, Inc. Protein kinase modulators and methods of use
ES2362998T3 (es) 2002-08-19 2011-07-18 Pfizer Inc. Terapia de combinación para enfermedades hiperproliferativas.
US6903105B2 (en) * 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
AU2004248859C1 (en) * 2003-06-26 2011-11-24 Biotron Limited Antiviral acylguanidine compounds and methods
CA2529949C (en) * 2003-06-26 2013-08-06 Biotron Limited Antiviral compounds and methods
US7326706B2 (en) * 2003-08-15 2008-02-05 Bristol-Myers Squibb Company Pyrazine modulators of cannabinoid receptors
SI1663235T1 (sl) * 2003-08-18 2013-12-31 Parion Sciences, Inc. Zaščiteni pirazinoilgvanidinski blokatorji natrijevega kanala
KR20060115348A (ko) * 2003-08-18 2006-11-08 패리온 사이언스 인코퍼레이티드 지방족 피라지노일구아니딘 나트륨 채널 차단제
US20050090505A1 (en) * 2003-08-18 2005-04-28 Johnson Michael R. Methods of reducing risk of infection from pathogens
US20090253714A1 (en) * 2003-08-20 2009-10-08 Johnson Michael R Methods of reducing risk of infection from pathogens
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
US20070099968A1 (en) * 2004-06-26 2007-05-03 Biotron Limited Antiviral compounds and methods
US20070021439A1 (en) * 2005-07-25 2007-01-25 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens with soluble amide and ester pyrazinoylguanidine sodium channel blockers
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
WO2007062222A2 (en) 2005-11-22 2007-05-31 University Of South Florida Inhibition of cell proliferation
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8404896B2 (en) 2006-12-01 2013-03-26 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as CETP inhibitors for the treatment of atherosclerosis and cardiovascular diseases
AU2008310734B2 (en) 2007-10-10 2014-06-05 Parion Sciences, Inc. Delivering osmolytes by nasal cannula
KR101654549B1 (ko) * 2008-02-26 2016-09-07 패리온 사이언스 인코퍼레이티드 다중방향족 나트륨 채널 차단제
DE102008053024B4 (de) 2008-10-24 2015-04-30 RUHR-UNIVERSITäT BOCHUM Verwendung von Amilorid-Derivaten zur Bekämpfung von Insekten und Milben
US8247436B2 (en) 2010-03-19 2012-08-21 Novartis Ag Pyridine and pyrazine derivative for the treatment of CF
US8945605B2 (en) 2011-06-07 2015-02-03 Parion Sciences, Inc. Aerosol delivery systems, compositions and methods
PT2723176T (pt) 2011-06-27 2017-07-18 Parion Sciences Inc Dipéptido química e metabolicamente estável que possui potente atividade bloqueadora do canal de sódio
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
BR112014029329A2 (pt) 2012-05-29 2017-06-27 Parion Sciences Inc aminoamidas semelhantes ao dendrímero possuindo atividade bloqueadora de canal de sódio para o tratamento de olho seco e outras doenças mucosais
AU2013363215B2 (en) 2012-12-17 2018-03-01 Parion Sciences, Inc. 3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
EP3150585A1 (en) 2012-12-17 2017-04-05 Parion Sciences, Inc. Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
AU2014255381A1 (en) 2013-04-17 2015-10-08 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
EP3019492B1 (en) * 2013-07-08 2017-09-06 Boehringer Ingelheim International GmbH Amiloride-type compounds as inhibitors in epithelial sodium channels for the treatment of diseases of the lungs and airways
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CA3030949A1 (en) 2016-07-29 2018-02-01 Toray Industries, Inc. Guanidine derivative and medical use thereof
MX2021008533A (es) 2019-01-18 2021-08-19 Astrazeneca Ab Inhibidores de la pcsk9 y metodos de uso de los mismos.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL299929A (fi) * 1962-10-30

Also Published As

Publication number Publication date
SE321230B (fi) 1970-03-02
CH465617A (de) 1968-11-30
DE1795438B1 (de) 1973-09-06
MY6900026A (en) 1969-12-31
DE1795438C2 (de) 1974-04-11
DK114557B (da) 1969-07-14
NL299931A (fi)
FI47102B (fi) 1973-05-31
BR6354164D0 (pt) 1973-09-18
NL142413B (nl) 1974-06-17
GB1066855A (en) 1967-04-26
BE639386A (fi)
CY440A (en) 1968-05-18
DE1470053A1 (de) 1969-06-26
DK116943B (da) 1970-03-02
FR1563612A (fi) 1969-04-18
US3313813A (en) 1967-04-11
FI47102C (fi) 1973-09-10
DK115403B (da) 1969-10-06

Similar Documents

Publication Publication Date Title
DK114978B (da) Fremgangsmåde til fremstilling af (3-amino-pyrazinoyl)-guanidin-forbindelser eller salte heraf.
DK121866B (da) Fremgangsmåde til fremstilling af aryloxyalkanolaminderivater eller salte deraf.
DK108310C (da) Fremgangsmåde til fremstilling af (3-aminopyrazinamido)-guanidinforbindelser eller syreadditionssalte heraf.
DK131907B (da) Fremgangsmåde til fremstilling af en alfa-aminobenzylpenicillin eller salte deraf.
DK104237C (da) Fremgangsmåde til fremstilling af imidazolforbindelser eller salte deraf.
DK107876C (da) Fremgangsmåde til fremstilling af phenylethanolaminer eller salte heraf.
DK111567B (da) Fremgangsmåde til fremstilling af piperidinderivater eller salte deraf.
DK118823B (da) Fremgangsmåde til fremstilling af 2-mercaptothiazolyl-benzimidazol-forbindelser eller salte deraf.
DK113576B (da) Fremgangsmåde til fremstilling af benzensulfonyl-semicarbazider eller salte deraf.
DK104064C (da) Fremgangsmåde til fremstilling af derivater af 4-sulfanilamid-pyrimidin eller salte deraf.
DK102805C (da) Fremgangsmåde til fremstilling af indoloquinolizinderivater eller salte heraf.
DK100117C (da) Fremgangsmåde til fremstilling af 3-cyclopropylaminomethylindolforbindelser eller salte heraf.
DK108863C (da) Fremgangsmåde til fremstilling af 1-halogenphenylethyl-2-methyl-1,2,3,4-tetrahydro-iso-quinolinforbindelser eller salte deraf.
DK104060C (da) Fremgangsmåde til fremstilling af α-aminobenzylpenicillin eller salte deraf.
DK109206C (da) Fremgangsmåde til fremstilling af desoxo-schizozygin eller desoxo-dihydro-schizozygin eller salte deraf.
DK100620C (da) Fremgangsmåde til fremstilling af 2-α-hydroxyalkyl-4-quinazoloner eller salte deraf.
DK105465C (da) Fremgangsmåde til fremstilling af 20-alkyl-20-aminosteroider eller salte deraf.
DK118244B (da) Fremgangsmåde til fremstilling af α-hydroxypenicilliner eller salte deraf.
DK118243B (da) Fremgangsmåde til fremstilling af α-hydroxypenicilliner eller salte deraf.
DK101361C (da) Fremgangsmåde til fremstilling af polyhydroxybenzylhydrazinforbindelser eller salte deraf.
DK115037B (da) Fremgangsmåde til fremstilling af hydroxybenzensulfonylurinstoffer eller disses salte.
DK98301C (da) Fremgangsmåde til fremstilling af 4-sulfonamido-5,6-dialkoxy-pyrimidiner eller salte deraf.
DK102182C (da) Fremgangsmåde til fremstilling af 3-sulfanilamido-4,5-dialkyl-isoxazoler eller salte deraf.
DK102518C (da) Fremgangsmåde til fremstilling af benzodiazepinforbindelser eller salte deraf.
DK95588C (da) Fremgangsmåde til fremstilling af 1,2,3,4,5,6,7,8-octahydro-iso-quinolinforbindelser eller salte deraf.